Evidence map›Paper›PMID 33123808›Full record

ArticleArchives of gynecology and obstetrics2021

Vaginal delivery in SARS-CoV-2-infected pregnant women in Israel: a multicenter prospective analysis.

Amihai Rottenstreich, Abraham Tsur, Nava Braverman, Doron Kabiri, Shay Porat, Shmuel Benenson, Yonatan Oster, Hadas Allouche Kam, Asnat Walfisch, Yossi Bart and 9 more

Abstract readMulticenter Study
In one paragraph

Article in Archives of gynecology and obstetrics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Observational
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Amihai Rottenstreich *Department of Obstetrics and Gynecology, Hadassah-Hebrew University Medical Center, POB 12000, 91120, Jerusalem, Israel.ORCID http://orcid.org/0000-0002-2472-5204
Abraham Tsur *Department of Obstetrics and Gynecology, Sheba Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Hashomer, 52621, Ramat Gan, Israel.
Nava BravermanDepartment of Obstetrics and Gynecology, Hadassah-Hebrew University Medical Center, POB 12000, 91120, Jerusalem, Israel.
Doron KabiriDepartment of Obstetrics and Gynecology, Hadassah-Hebrew University Medical Center, POB 12000, 91120, Jerusalem, Israel.
Shay PoratDepartment of Obstetrics and Gynecology, Hadassah-Hebrew University Medical Center, POB 12000, 91120, Jerusalem, Israel.
Shmuel BenensonDepartment of Clinical Microbiology and Infectious Diseases, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Yonatan OsterDepartment of Clinical Microbiology and Infectious Diseases, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Hadas Allouche KamDepartment of Obstetrics and Gynecology, Hadassah-Hebrew University Medical Center, POB 12000, 91120, Jerusalem, Israel.
Asnat WalfischDepartment of Obstetrics and Gynecology, Hadassah-Hebrew University Medical Center, POB 12000, 91120, Jerusalem, Israel.
Yossi BartDepartment of Obstetrics and Gynecology, Sheba Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Hashomer, 52621, Ramat Gan, Israel.
Raanan MeyerDepartment of Obstetrics and Gynecology, Sheba Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Hashomer, 52621, Ramat Gan, Israel.
Shirlee Jaffe LifshitzDepartment of Obstetrics and Gynecology, Mayenei Hayeshua Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Ramat Gan, Israel.
Uri AmikamDepartment of Obstetrics and Gynecology, Lis Maternity Hospital, Sourasky Medical Center, Tel-Aviv, Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.
Tal Biron-ShentalDepartment of Obstetrics and Gynecology, Meir Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Kfar Saba, Israel.
Gal CohenDepartment of Obstetrics and Gynecology, Meir Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Kfar Saba, Israel.
Yael Sciaky-TamirDepartment of Obstetrics and Gynecology, Ziv Medical Center, Safed Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
Inbar Ben ShacharDepartment of Obstetrics and Gynecology, Ziv Medical Center, Safed Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
Yoav YinonDepartment of Obstetrics and Gynecology, Sheba Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Hashomer, 52621, Ramat Gan, Israel. yoav.yinon27@gmail.com.
Benjamin ReubinoffDepartment of Obstetrics and Gynecology, Hadassah-Hebrew University Medical Center, POB 12000, 91120, Jerusalem, Israel. benr@hadassah.org.il.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

key messageAmong SARS-CoV-2-infected mothers, vaginal delivery rates were high and associated with favorable outcomes with no cases of neonatal COVID-19. PURPOSE: To investigate the mode of delivery and its impact on immediate neonatal outcome in SARS-CoV-2-infected women.

methodsA prospective study following pregnant women diagnosed with COVID-19 who delivered between March 15th and July 4th in seven university affiliated hospitals in Israel.

resultsA total of 52 women with a confirmed diagnosis of COVID-19 delivered in the participating centers during the study period. The median gestational age at the time of delivery was 38 weeks, with 16 (30.8%) cases complicated by spontaneous preterm birth. Forty-three women (82.7%) underwent a trial of labor. The remaining 9 women underwent pre-labor cesarean delivery mostly due to obstetric indications, whereas one woman with a critical COVID-19 course underwent urgent cesarean delivery due to maternal deterioration. Among those who underwent a trial of labor (n = 43), 39 (90.7%) delivered vaginally, whereas 4 (9.3%) cases resulted in cesarean delivery. Neonatal RT-PCR nasopharyngeal swabs tested negative in all cases, and none of the infants developed pneumonia. No maternal and neonatal deaths were encountered.

conclusionsIn this prospective study among SARS-CoV-2-infected mothers, vaginal delivery rates were high and associated with favorable outcomes with no cases of neonatal COVID-19. Our findings underscore that delivery management among SARS-CoV-2-infected mothers should be based on obstetric indications and may potentially reduce the high rates of cesarean delivery previously reported in this setting.

Indexed as

Pregnant PeopleSARS-CoV-2AdultCesarean SectionCOVID-19Delivery, ObstetricFemaleGestational AgeHumansInfant, NewbornInfectious Disease Transmission, VerticalIsraelPandemicsPerinatal DeathPregnancyPregnancy Complications, InfectiousCOVID-19DeliveryOutcomesPregnancyVaginal

Identifiers

PMID33123808
PMCPMC7594971

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.